1. Home
  2. TENX vs FCUV Comparison

TENX vs FCUV Comparison

Compare TENX & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • FCUV
  • Stock Information
  • Founded
  • TENX 1967
  • FCUV 2012
  • Country
  • TENX United States
  • FCUV United States
  • Employees
  • TENX N/A
  • FCUV N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • FCUV Industrial Machinery/Components
  • Sector
  • TENX Health Care
  • FCUV Industrials
  • Exchange
  • TENX Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • TENX 27.3M
  • FCUV 31.5M
  • IPO Year
  • TENX N/A
  • FCUV N/A
  • Fundamental
  • Price
  • TENX $7.34
  • FCUV $4.32
  • Analyst Decision
  • TENX Strong Buy
  • FCUV
  • Analyst Count
  • TENX 3
  • FCUV 0
  • Target Price
  • TENX $16.67
  • FCUV N/A
  • AVG Volume (30 Days)
  • TENX 96.6K
  • FCUV 55.3K
  • Earning Date
  • TENX 11-14-2025
  • FCUV 11-14-2025
  • Dividend Yield
  • TENX N/A
  • FCUV N/A
  • EPS Growth
  • TENX N/A
  • FCUV N/A
  • EPS
  • TENX N/A
  • FCUV N/A
  • Revenue
  • TENX N/A
  • FCUV $432,983.00
  • Revenue This Year
  • TENX N/A
  • FCUV N/A
  • Revenue Next Year
  • TENX N/A
  • FCUV N/A
  • P/E Ratio
  • TENX N/A
  • FCUV N/A
  • Revenue Growth
  • TENX N/A
  • FCUV 140.82
  • 52 Week Low
  • TENX $4.32
  • FCUV $1.80
  • 52 Week High
  • TENX $8.24
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • TENX 54.72
  • FCUV 57.79
  • Support Level
  • TENX $7.00
  • FCUV $3.87
  • Resistance Level
  • TENX $7.72
  • FCUV $4.37
  • Average True Range (ATR)
  • TENX 0.49
  • FCUV 0.45
  • MACD
  • TENX -0.02
  • FCUV -0.01
  • Stochastic Oscillator
  • TENX 75.12
  • FCUV 55.92

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: